MaxCyte (LON:MXCT) Stock Price Passes Above 50-Day Moving Average – What’s Next?

MaxCyte, Inc. (LON:MXCT) shares passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 0.80 and traded as high as GBX 0.86. MaxCyte shares last traded at GBX 0.85, with a volume of 395,334 shares trading hands.

MaxCyte Price Performance

The company has a market capitalization of £926,570.09, a price-to-earnings ratio of -0.02 and a beta of 1.13. The company has a current ratio of 12.39, a quick ratio of 14.38 and a debt-to-equity ratio of 9.70. The company has a 50 day moving average price of GBX 0.80 and a 200 day moving average price of GBX 1.18.

MaxCyte Company Profile

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.